cephalosporin c has been researched along with malondialdehyde in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cojocel, C | 1 |
Baumann, K; Cojocel, C; Göttsche, U; Tölle, KL | 1 |
Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P | 1 |
Owada, S; Yokozawa, T | 1 |
Mykhaĭlovych, IuI | 1 |
Dionyssiou-Asteriou, A; Dontas, I; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Plachouras, D; Raftogiannis, M; Skiathitis, S | 1 |
Baumann, K; Cojocel, C; El-Hajj, H; Tolle, KL | 1 |
Chaudhary, M; Dwivedi, VK; Soni, A | 1 |
Chaudhary, M; Dwivedi, VK; Shrivastava, SM; Singh, CP; Soni, A | 1 |
9 other study(ies) available for cephalosporin c and malondialdehyde
Article | Year |
---|---|
Biochemical aspects of the renal tolerance for cefpirome and other cephalosporins.
Topics: Animals; Cefotaxime; Cefpirome; Cephalosporins; Cytosol; Gluconeogenesis; Glutathione; In Vitro Techniques; Kidney Cortex; Kidney Diseases; L-Lactate Dehydrogenase; Male; Malondialdehyde; Oxidation-Reduction; Rats; Rats, Inbred Strains; Tetraethylammonium; Tetraethylammonium Compounds | 1990 |
Nephrotoxic potential of first-, second-, and third-generation cephalosporins.
Topics: Animals; Cephalosporins; Gluconeogenesis; Kidney Diseases; Lipid Peroxides; Male; Malondialdehyde; Rats; Rats, Inbred Strains; Tetraethylammonium Compounds | 1988 |
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
Topics: Amikacin; Ampicillin Resistance; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Gentamicins; Imipenem; Lipid Peroxidation; Malondialdehyde; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Species Specificity; Thienamycins; Ticarcillin; Tobramycin; Vitamin E | 1998 |
Effect of ginsenoside-Rd in cephaloridine-induced renal disorder.
Topics: Animals; Blood Urea Nitrogen; Catalase; Cephaloridine; Cephalosporins; Creatinine; Ginsenosides; Glycosuria; Hypolipidemic Agents; Kidney Diseases; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Lipid Peroxidation; LLC-PK1 Cells; Male; Malondialdehyde; Potassium; Rats; Rats, Wistar; Reactive Oxygen Species; Saponins; Sodium; Superoxide Dismutase; Swine | 1999 |
[The effect of the regimen for administering antibacterial therapy on the manifestations of endogenous intoxication in patients operated on for lung cancer].
Topics: Antibiotic Prophylaxis; Biomarkers; Cefotaxime; Cephalosporins; Humans; Lung Neoplasms; Malondialdehyde; Postoperative Care; Preoperative Care; Retrospective Studies; Sepsis; Superoxide Dismutase; Time Factors | 1999 |
Ex vivo synergy of arachidonate-enriched serum with ceftazidime and amikacin on multidrug-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporins; Colony Count, Microbial; Culture Media; Drug Resistance, Multiple, Bacterial; Drug Synergism; Lipid Peroxides; Male; Malondialdehyde; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits; Thiobarbituric Acid Reactive Substances; Time Factors | 2003 |
Protection against cephalosporin-induced lipid peroxidation and nephrotoxicity by (+)-cyanidanol-3 and vitamin E.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Catechin; Cephalosporins; Glutathione; Kidney Cortex; Kidney Function Tests; Lipid Peroxidation; Liver; Male; Malondialdehyde; Rats; Rats, Wistar; Vitamin E | 2007 |
Fixed dose combination of cefepime plus amikacin prevent oxidative stress in liver of Mus musculus mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Catalase; Cefepime; Cephalosporins; Drug Combinations; Lipid Peroxidation; Liver; Malondialdehyde; Mice; Oxidative Stress; Superoxide Dismutase | 2008 |
Fixed-dose combination of cefepime plus amikacin (potentox) inhibits pneumonia infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Catalase; Cefepime; Cephalosporins; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Pneumonia, Bacterial; Rats; Rats, Wistar; Superoxide Dismutase | 2009 |